Things are moving at breakneck speed with the Intergenerational Blood Pressure Study. We began participant enrollment in April 2015 and to date, we have 13 families participating in the study. Over the next 2 years, we plan to enroll 250 families across CT. A total of 12 Head Start centers and early care and education centers in Bridgeport, New Haven, Hartford, East Hartford, Meriden, and West Haven are partnering with Intergen to recruit families. We are extremely grateful to our community partners and truly appreciate their investment and dedication to our project. Our success is due to all their enthusiasm and hard work spreading the word about our study!
We will be seeking additional community partners, so if you or an agency you know is interested in working with us, please contact Valen Grandelski at valen.grandelski@yale.edu or 203-737-8298.
Our team has expanded to include student interns, research interns, post-doctoral fellows, and others. The Intergen study owes its progress to all of the fabulous team members and their contributions. We have welcomed a few new team members recently and they will be out in the field recruiting and collecting data as our study grows. Be on the lookout for new friendly faces from the Intergen study! If you are interested in helping out with our project, please email Valen Grandelski at valen.grandelski@yale.edu with your resume and research interests.
We are actively recruiting and enrolling participants from our early care and education sites and from events for the community at large. Check out our Get Involved tab. We are looking for:
- Black/African American mothers and their biological children
- Mothers age 21 years and older
- Children ages 3-5 years
If you or someone you know is interested in learning more about our study, please contact Comfort Agaba at 203-737-3843 or 844-288-2344 (toll-free).
The focus of the coming months will be recruitment and data collection. We are working hard to enroll participants in our study and get people excited about our research. We are looking forward to reporting back on future developments as our study progresses. Thank you all for your support of the Intergen study.